Bispecific killer cell engages (BiKEs) containing ScFv fragments that target CD16 and a tumor antigen are one example of this, and have been used to target EpCAM on carcinomas (114), CD133 on cancer stem cells (115), and CD30 on lymphomas (116). The gene discussed is FCGR3A; the disease is neoplasm.